デジタル・セラピューティクスの世界市場

デジタル・セラピューティクスの世界市場は2030年に329億米ドルに到達へ

COVID-19後の変化したビジネス環境において、2022年に44億米ドルと推定されるデジタル・セラピューティクスの世界市場は、2030年には329億米ドルに達すると予測され、2022年から2030年にかけてCAGR 28.7%で成長するとされています。本レポートで分析しているセグメントの一つであるB2Bは、CAGR29.6%を記録し、分析期間終了時には309億米ドルに達すると予測されます。パンデミック後の回復を考慮し、B2Cセグメントの成長は、今後8年間のCAGRが19.8％に修正されました。

米国市場は17億米ドル、中国はCAGR31.8%で成長する見通し

米国のデジタル・セラピューティクス市場は、2022年に17億米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが31.8％となり、2030年には32億米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ25.2％と23.4％の成長が予測されています。欧州では、ドイツがCAGR28.7%で成長すると予測されています。

調査対象企業の例

• AstraZeneca PLC
• 2Morrow, Inc.
• Click Therapeutics, Inc.
• Canary Health Inc.
• Adherium（NZ）Limited
• AppliedVR, Inc.
• Cognoa, Inc.
• Amiko Digital Health Limited
• Atentiv LLC
• CureApp, Inc.
• Biofourmis
• Behaivior
• BehaVR
• Aidar Health
• Cara Care

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• 世界のその他の地域

第4章 競合

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Digital Therapeutics Market to Reach $32.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Digital Therapeutics estimated at US$4.4 Billion in the year 2022, is projected to reach a revised size of US$32.9 Billion by 2030, growing at aCAGR of 28.7% over the period 2022-2030. B2B, one of the segments analyzed in the report, is projected to record 29.6% CAGR and reach US$30.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the B2c segment is readjusted to a revised 19.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 31.8% CAGR

The Digital Therapeutics market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 31.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 25.2% and 23.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 28.7% CAGR.

Select Competitors (Total 136 Featured) -

• AstraZeneca PLC
• 2Morrow, Inc.
• Click Therapeutics, Inc.
• Canary Health Inc.
• Adherium (NZ) Limited
• AppliedVR, Inc.
• Cognoa, Inc.
• Amiko Digital Health Limited
• Atentiv LLC
• CureApp, Inc.
• Biofourmis
• Behaivior
• BehaVR
• Aidar Health
• Cara Care

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Digital Therapeutics is Poised to Benefit from the Increasingly Robust Outlook for Digital Health
  • Digital Healthcare Sets the Stage for the Rise of Digital Therapeutics: Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
  • Global Economic Update
  • Shaken by the War, Global Oil Prices Spiral and Feed Inflationary Pressures, Guiding the World Towards a Cost of Living Crisis: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2017 through 2024
  • War-Induced Commodity Price Increases & Broad Based Price Pressures Mark the Return of Global Inflation to the Highest Level Seen Since 1996: Global Inflation Rates (In %) for the Years 2019 Through 2024
  • Although Facing a Lower Recession Risk, Global Economic Growth in 2023 to Slowdown Amid War, Inflation, Elevated Interest Rates & Marginal Easing of Inflation: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024
  • Recession Triggered by Uncontrolled Inflation or Unemployment, Which is the Greater Evil? Inflation Battling Policy Measures to Slowdown Post Pandemic Recovery in Unemployment Rates: Global Number of Unemployed People (In Million) for Years 2019 Through 2024
  • Competition
  • Digital Therapeutics - Global Key Competitors Percentage Market Share in 2023 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
  • Digital Therapeutics: Overview & Market Outlook
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Global Focus on Meeting Unmet Needs in Mental Healthcare to Benefit Growth of Digital Therapeutics
  • Shockingly High Burden of Mental Disorders & the Ensuing Focus to Meet Unmet Care Needs Primes Digital Therapeutics for Mass Adoption: Global Economic Cost of Mental Illnesses (In US$ Trillion) for Years 2023, 2025, 2027, 2029 & 2031
  • Artificial Intelligence to Play a Key Role in Improving the Effectiveness of Digital Therapeutics
  • High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
  • Rising Prevalence of Chronic Diseases Amplifies the Need for Addressing Management of These Diseases Through Digital Therapeutics: Global Cost of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
  • Here's How Digital Therapeutics Can Help Improve Clinical Outcomes Across the Cardiac Continuum
  • Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
  • How Digital Therapeutics is Changing the Oncology Care Landscape?
  • Worrisome Epidemic Increase in Cancer Incidence to Help Accelerate Adoption of Digital Therapeutics: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Rise of mHealth & Smart Medical Devices & Wearables Paves the Way for More Spontaneous Adoption of Digital Therapeutics
  • Growing Familiarity with mHealth & Use of Medical Wearables Means There is One Less Obstacle in the Implementation of Digital Therapeutics: Global Market for mHealth & Medical Wearables (In US$ Billion) for Years 2023, 2025, 2027, 2029 and 20231
  • As Healthcare Costs Continue to Spiral, Growing Much Faster Than National GDP, Focus Shifts to Digital Therapeutics for its Ability to Lower Cost of Care
  • Growing Urgency to Rein-in Spiraling Healthcare Costs Leads Healthcare Community to Take a Closer Look at Digital Therapeutics: Healthcare Costs as a % of GDP by Country 2020 VS 2023
  • Growing Preference for Personalized Medicine Doubles the Focus on Digital Therapeutics
  • Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Digital Therapeutics: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
  • Here's How AR/VR Technologies are Changing the Future of Digital Therapeutics
  • The Many Benefits of 5G in Healthcare to Catalyze Adoption of Digital Therapeutics
  • Rapid Penetration of 5G Will Make Implementation of Digital Therapeutics Seamless & More Efficient to Use: Global 5G Subscription (In Million) for Years 2023, 2025, 2027 and 2029
  • Technology and Innovation to Continue to Drive Adoption of Digital Therapeutics
  • Cybersecurity Storms Into the Spotlight. Here's Why
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Digital Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 3: World 8-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World 8-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 7: World 8-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Treatment / Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 9: World 8-Year Perspective for Treatment / Care by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World 8-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • TABLE 12: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 13: USA 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 14: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 15: USA 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• CANADA
  • TABLE 16: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 17: Canada 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 18: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 19: Canada 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• JAPAN
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 21: Japan 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 22: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 23: Japan 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• CHINA
  • TABLE 24: China Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 25: China 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 26: China Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 27: China 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• EUROPE
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • TABLE 28: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 29: Europe 8-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • TABLE 30: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 31: Europe 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 33: Europe 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• FRANCE
  • TABLE 34: France Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 35: France 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 36: France Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 37: France 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• GERMANY
  • TABLE 38: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 39: Germany 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 40: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 41: Germany 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• ITALY
  • TABLE 42: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 43: Italy 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 44: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 45: Italy 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• UNITED KINGDOM
  • TABLE 46: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 47: UK 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 48: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 49: UK 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 51: Rest of Europe 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 53: Rest of Europe 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• ASIA-PACIFIC
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 55: Asia-Pacific 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030
• REST OF WORLD
  • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 59: Rest of World 8-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2023 & 2030
  • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 61: Rest of World 8-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2023 & 2030

IV. COMPETITION